Core A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the Penn Mental Health AIDS Research Center (PMHARC), enabling it to fulfill its core mission to transform how people with both mental illness and HIV/AIDS (mental illness/AIDS) are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center and Gore A will be led by a Director and two Go-Directors with exceptional and complementary strengths and experience in administration, research, and training and in the study of comorbid mental illness/AIDS. PMHARG will be located in an optimal intellectual and resource environment, which encompasses robust and well-regarded mental illness and AIDS research communities on the University of Pennsylvania and Children's Hospital of Philadelphia contiguous campuses. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments. Gore A will create an interactive environment that fosters communication, collaboration, and synergy among Center components and participants, as well as with the relevant schools, departments, centers, and institutes at Penn/CHOP and with other NIMH AIDS Research Centers. This proactive Core will be engaged and responsible for: 1) coordinating interdisciplinary and collaborative mental health and AIDS research activities;2) encouraging, supporting, and mentoring new, established, and transitional investigators to focus on comorbid mental illness/AIDS, and related comorbidities;3) developing vibrant and responsive Strategic Planning, Monitoring, and Evaluation Processes and comprehensive Policies and Procedures;4) managing fiscal matters;5) conducting educational and community outreach programs;6) fostering national linkages among other NIMH AIDS Research Centers;and 7) establishing an active Community Advisory Board (GAB). Core A will include the Center Director, 2 Co-Directors, Executive Committee (EC), Internal Advisory Board (lAB), External Advisory Committee (EAC), Gross-Talk Committee, and CAB. This structure of Gore A is explicitly intended to allow for continuous monitoring and evaluation of PMHARC functioning in order to optimize efficiencies and responsiveness.

Public Health Relevance

Gore A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the proposed Center, enabling it to transform how people with both mental illness and HIV/AIDS are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH097488-02
Application #
8670022
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
$303,433
Indirect Cost
$113,787
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hill, David A; Lim, Hee-Woong; Kim, Yong Hoon et al. (2018) Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue. Proc Natl Acad Sci U S A 115:E5096-E5105
Opondo, Philip R; Ho-Foster, Ari R; Ayugi, James et al. (2018) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. AIDS Behav 22:1503-1516
Schnoll, Robert A; Thompson, Morgan; Serrano, Katrina et al. (2018) Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research. J Acquir Immune Defic Syndr :
Torgersen, Jessie; Bellamy, Scarlett L; Ratshaa, Bakgaki et al. (2018) Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans. Eur J Drug Metab Pharmacokinet :
Dalseth, Natasha; Reed, Regina Szucs; Hennessy, Michael et al. (2018) Does Diagnosis Make a Difference? Estimating the Impact of an HIV Medication Adherence Intervention for Persons with Serious Mental Illness. AIDS Behav 22:265-275
Crits-Christoph, Paul; Gallop, Robert; Noll, Elizabeth et al. (2018) Impact of a medical home model on costs and utilization among comorbid HIV-positive Medicaid patients. Am J Manag Care 24:368-375
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Momplaisir, Florence M; Aaron, Erika; Bossert, Lisa et al. (2018) HIV care continuum outcomes of pregnant women living with HIV with and without depression. AIDS Care 30:1580-1585
Vujkovic, Marijana; Bellamy, Scarlett L; Zuppa, Athena F et al. (2018) Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana. Pharmacogenomics J 18:678-688
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :

Showing the most recent 10 out of 74 publications